Unilever upgrades 2026 outlook as volume growth accelerates
Unilever's first-half sales growth reached 4.8%, led by higher volumes, prompting upgraded guidance despite pressure from currency and Foods.
This article covers information on Unilever PLC.
LON:ULVRUnilever PLC has upgraded its full-year outlook after reporting a strong, volume-led performance for the first half of 2026.
Underlying sales growth reached 4.8%, driven mainly by customers buying more products rather than Unilever relying on price rises. The pace accelerated during the second quarter, when underlying sales grew 5.8% and volumes increased 5.5%.
That second-quarter volume performance was Unilever's best in more than a decade. The key question for investors is whether this momentum can continue as pricing becomes a bigger part of growth during the second half.
Unilever's first-half results at a glance
| Metric | First half 2026 | Change |
|---|---|---|
| Turnover | €25.6 billion | 0.5% |
| Underlying sales growth | 4.8% | Not applicable |
| Underlying volume growth | 4.2% | Not applicable |
| Underlying price growth | 0.6% | Not applicable |
| Underlying operating profit | €5.2 billion | 0.9% |
| Underlying operating margin | 20.3% | Up 10 basis points |
| Underlying EPS | €1.61 | 2.4% |
| Diluted EPS | €1.38 | Down 2.5% |
| Free cash flow | €1.5 billion | Up from €1.1 billion |
| Net debt | €26.0 billion | Up from €23.1 billion |
Underlying sales growth strips out acquisitions, disposals and currency movements to provide a clearer view of trading performance. Volume growth measures the contribution from the amount and mix of products sold.
The 4.2% first-half volume increase is therefore encouraging. It suggests Unilever's growth was supported by genuine consumer demand rather than being heavily dependent on raising prices.
Reported turnover rose just 0.5% to €25.6 billion because a 4.9% adverse currency impact offset much of the operational growth.
Power Brands drive the strongest growth
Unilever's Power Brands accounted for 78% of turnover and delivered underlying sales growth of 6.0%, including 5.4% volume growth.
These larger brands remain central to management's strategy of concentrating investment on fewer, more scalable products. Dove, Sunsilk and Vaseline each achieved double-digit, volume-led growth within Beauty & Wellbeing.
Performance across the four business groups was mixed, although each delivered volume-led growth during the half.
| Business group | Underlying sales growth | Volume growth | Underlying margin |
|---|---|---|---|
| Beauty & Wellbeing | 5.9% | 4.5% | 19.5% |
| Personal Care | 4.8% | 4.1% | 22.2% |
| Home Care | 7.6% | 7.4% | 15.8% |
| Foods | 1.2% | 1.2% | 23.3% |
Home Care was the fastest-growing division, helped by India and Brazil. Its underlying sales increased 7.6%, with nearly all of that coming from volume.
Beauty & Wellbeing also performed well. Growth accelerated to 8.1% in the second quarter, supported by Dove, Sunsilk, Vaseline and Unilever's prestige beauty brands.
Foods remains the weak spot
Foods was clearly the least impressive part of the update. First-half underlying sales growth was 1.2%, slowing to just 0.2% during the second quarter.
Management highlighted softer developed markets and increased competition in US condiments. Unilever is taking action to address lost market share in premium and avocado mayonnaise, with improved performance expected during the second half.
Foods underlying operating profit fell 4.3%, although its underlying margin remained flat at 23.3%. Commodity inflation and additional investment in the customer proposition put pressure on gross margin.
This matters because Unilever plans to combine Foods with McCormick. The separation work is progressing, but completion is not expected until mid-2027 at the latest and remains subject to shareholder and regulatory approvals.
The proposed transaction would leave Unilever as a more focused health and personal care business, but investors still need to account for execution, regulatory and integration risks.
Emerging markets provide the momentum
Emerging markets generated 60% of group turnover and delivered underlying sales growth of 7.0%, including 5.8% volume growth. Growth accelerated to 8.3% during the second quarter.
India grew 8% in the first half and 10% in the second quarter. Indonesia grew 7%, while Latin America delivered 7.6% growth. Brazil returned to double-digit growth during the second quarter following corrective actions taken during 2025.
Developed markets were more subdued, with underlying sales growth of 1.5%. North America grew 2.7%, supported by Personal Care and prestige beauty, but Europe declined 0.9% amid softer markets and weaker Foods pricing.
This geographical split is important. Emerging markets are providing meaningful volume growth, but they can also expose reported results to currency volatility. That was visible in the 4.9% currency headwind against first-half turnover.
Margins hold despite cost pressure
Underlying operating margin increased by 10 basis points to 20.3%. A basis point is one-hundredth of a percentage point.
Gross margin fell 70 basis points to 46.8%, reflecting commodity inflation, promotional spending and restrained pricing. However, lower overheads offset this pressure.
Unilever completed its €800 million productivity programme ahead of schedule. The programme was launched in 2024 to simplify the business and remove costs left behind following the Ice Cream separation.
Brand and marketing investment remained substantial at 16.1% of turnover. Maintaining investment while protecting the overall operating margin is a positive feature of the results, although gross-margin pressure remains worth watching.
Cash flow improves, but debt moves higher
Free cash flow increased to €1.5 billion from €1.1 billion. The improvement reflected slightly higher operating profit and better working capital, partly offset by increased tax payments and capital expenditure.
Net debt, however, rose to €26.0 billion from €23.1 billion at the end of 2025. This was driven by dividends and the €1.5 billion share buyback completed during the first half.
The net debt-to-underlying EBITDA ratio stood at 2.3 times. Unilever expects this to fall to around two times by the end of 2026, but delivery will depend on cash generation and capital allocation.
The quarterly dividend is €0.4664 per share, unchanged from the first quarter and 3.0% higher than the second-quarter dividend for 2025. Unilever also expects separation proceeds and operational performance to support total buybacks of €6 billion between 2026 and 2029.
Upgraded guidance raises the second-half test
Unilever now expects full-year underlying sales growth within its 4% to 6% multi-year range, with around 3% volume growth. Second-half underlying sales growth is expected to be 4% to 5%, led by pricing.
Management also anticipates a modest improvement in the full-year underlying operating margin from 20.0% in 2025.
The first half provides a solid starting point. Volumes are growing, Power Brands are outperforming and the productivity programme is complete. The main areas to monitor are the expected shift towards pricing, weaker Foods performance, commodity pressure, currency movements and the rise in net debt.
Investors can review the figures and full statutory disclosures in the original company announcement.
What investors should watch next
The next test is whether Unilever can maintain healthy volumes as price growth accelerates. Successful delivery would support margins and reinforce the strength of its brands, while a sharp volume slowdown would weaken the quality of the upgraded outlook.
Progress on the McCormick transaction will also remain important. For now, the half-year results show stronger operating momentum, but the balance between pricing, volumes, costs and debt will determine whether that momentum translates into sustained earnings and cash-flow growth.
Related
Keep reading
Investing
Hostelworld interim results 2026: stronger revenue, but volume growth stays modest
Hostelworld lifted first-half revenue and EBITDA, moved into net cash and kept guidance, although transaction growth remained modest.
JoshuaJuly 29, 2026
Investing
Valterra Platinum Interim Results: EBITDA Quadruples as Dividend Jumps to R57
Valterra Platinum quadrupled adjusted EBITDA and moved into net cash, but three work-related fatalities overshadowed the strong results.
JoshuaJuly 29, 2026
Investing
KRM22 ARR Reaches £7.9 Million as Growth Investment Weighs on EBITDA
KRM22 delivered further recurring revenue growth in H1 2026, although lower EBITDA and delayed sales conversions provide reasons for caution.
JoshuaJuly 29, 2026
Tagged
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.